A Rare Case of Subacute Sclerosing Panencephalitis Presenting As Generalized Seizure

Nabin Simkhada1, Prakash Adhikari2, Bishnu D Pathak3

  • 1Internal Medicine, Nepalese Army Institute of Health Sciences, Kathmandu, NPL.

Cureus
|June 23, 2021
PubMed

Insights

Subacute sclerosing panencephalitis (SSPE) is a fatal measles complication. This case highlights the severe progression of SSPE, emphasizing the lack of a definitive cure despite symptomatic management.

Area of Science:

  • Neurology
  • Virology
  • Pediatrics

Background:

  • Subacute sclerosing panencephalitis (SSPE) is a rare, fatal neurological complication following measles infection.
  • It typically manifests years after the initial measles illness, leading to progressive neurological deterioration.

Observation:

  • A 16-year-old male presented with rapid decline in motor and cognitive functions, seizures, and incontinence.
  • History revealed measles infection at two months of age.
  • Clinical presentation included elevated measles antibody titers, characteristic EEG abnormalities, and MRI findings consistent with SSPE.

Findings:

  • The patient's condition worsened despite symptomatic treatment.
  • Diagnostic investigations confirmed probable SSPE.
  • The case illustrates the aggressive natural history of the disease in the absence of effective treatment.

Implications:

  • This case underscores the critical need for effective preventative strategies against measles to prevent SSPE.
  • Further research into novel therapeutic interventions for SSPE is warranted.
  • Highlights the importance of early diagnosis and supportive care in managing SSPE patients.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
839
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
565
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
562
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
858